TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 8 | -0 | 1 | -2 | 5 | 12 | 29 | 7 |
| S | %wins | 75 | 75 | 50 | 38 | 25 | 29 | 49 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/10/18 21:00 | 1/8/18 | MYL | Mylan N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | X0 | DO | CEO | S.m | -3,375 | 45.00 | 0 | -75 | -9 | 768 | D | ||||||||||||||
8/11/16 19:01 | 8/9/16 | MYL | Mylan N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | X0 | DO | CEO | S | -5,010 | 50.00 | 33 | -100 | -11 | 829 | D | 8 | -15 | -3 | 23 | 13 | 4 | 4 | 1 | -1 | 0 | -18 | -24 | -19 | |
2/3/15 20:55 | 1/30/15 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | PA | DO | CEO | S.dm | -21,897 | 53.15 | 33 | -412 | -43 | 546 | D | 88 | 17 | 8 | 2 | -6 | -4 | -2 | -4 | -3 | -3 | 2 | 35 | 1 | -7 |
11/26/14 18:05 | 11/24/14 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | PA | DO | CEO | S.dm | -5,580 | 55.80 | 33 | -100 | -25 | 295 | D | 108 | 27 | 13 | 17 | 19 | 5 | 4 | 2 | 0 | -1 | -2 | -2 | 25 | -12 |
4/16/14 19:00 | 4/14/14 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | PA | DO | CEO | S.d | -3,456 | 46.07 | 33 | -75 | -20 | 295 | D | 106 | 63 | 17 | 0 | -17 | -6 | -9 | -2 | -1 | 7 | 2 | 10 | -1 | 42 |
9/6/13 17:31 | 9/6/13 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | PA | DO | CEO | S.d | -5,656 | 35.35 | 33 | -160 | -41 | 231 | D | 77 | 52 | 17 | 18 | 10 | -1 | 1 | 2 | 3 | 10 | 14 | 21 | 55 | 33 |
3/20/13 19:49 | 3/18/13 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | PA | DO | CEO | S.d | -362 | 30.15 | 33 | -12 | -5 | 231 | D | 46 | 34 | 27 | 10 | 6 | 8 | 0 | -1 | -2 | -6 | -9 | 4 | 25 | 73 |
12/21/12 19:30 | 12/19/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | PA | DO | CEO | S.d | -4,208 | 27.78 | 33 | -152 | -47 | 173 | D | 31 | 35 | 29 | 14 | 8 | 2 | 0 | -1 | 0 | -3 | 1 | 5 | 9 | 53 |
3/29/12 16:57 | 3/28/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Bresch Heather M | PA | DO | CEO | S.d | -4,566 | 23.14 | 33 | -197 | -53 | 173 | D | 2 | 3 | 25 | 8 | 0 | 3 | 1 | 1 | 1 | 0 | -5 | -10 | 4 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |